Bayer devotes funds to research glyphosate alternatives

Tim Loh,
Naomi Kresge and Bloomberg, writing for Fortune,
report that Bayer AG will pump about 5 billion euros ($5.6 billion) of its
research and development budget into alternatives to its weedkiller glyphosate
over the next decade as it battles more than 13,000 lawsuits claiming the herbicide
causes cancer.

Trying to ease concerns about the controversial compound, the German chemical and drug company said it will seek more public feedback during the coming safety certification process in Europe. Bayer wants to offer farmers new products to combat weeds while standing behind glyphosate-based Roundup, which it acquired via its $63 billion purchase of Monsanto. Read it all here